Wen SWC, Nederby L, Andersen RF, Hansen TS, et al. NK cell activity and methylated HOXA9 ctDNA as prognostic biomarkers in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors. Br J Cancer 2023 May 3. doi: 10.1038/s41416-023-02285.
PMID: 37137997